WEC
AMGN icon

Winslow Evans & Crocker’s Amgen AMGN Stock Holding History

Winslow Evans & Crocker’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3.02M Buy
13,138
+4,190
+47% +$966K 0.57% 36
2020
Q3 		$2.27M Buy
8,948
+2,415
+37% +$598K 0.56% 39
2020
Q2 		$1.54M Buy
6,533
+321
+5% +$73.2K 0.41% 53
2020
Q1 		$1.26M Sell
6,212
-76
-1% -$16.6K 0.41% 59
2019
Q4 		$1.52M Sell
6,288
-44
-0.7% -$9.7K 0.39% 59
2019
Q3 		$1.23M Buy
6,332
+2
+0% +$384 0.34% 68
2019
Q2 		$1.17M Buy
6,330
+74
+1% +$13.3K 0.33% 70
2019
Q1 		$1.19M Buy
6,256
+162
+3% +$30.9K 0.34% 68
2018
Q4 		$1.19M Sell
6,094
-42
-0.7% -$8.19K 0.4% 58
2018
Q3 		$1.27M Buy
6,136
+90
+1% +$17.7K 0.39% 58
2018
Q2 		$1.12M Sell
6,046
-30
-0.5% -$5.31K 0.35% 66
2018
Q1 		$1.04M Hold
6,076
– – 0.34% 71
2017
Q4 		$1.06M Hold
6,076
– – 0.34% 73
2017
Q3 		$1.13M Sell
6,076
-289
-5% -$51.2K 0.38% 61
2017
Q2 		$1.1M Buy
6,365
+529
+9% +$86K 0.3% 80
2017
Q1 		$957K Hold
5,836
– – 0.3% 69
2016
Q4 		$853K Sell
5,836
-88
-1% -$13.2K 0.26% 86
2016
Q3 		$988K Sell
5,924
-82
-1% -$13.9K 0.28% 77
2016
Q2 		$914K Sell
6,006
-22
-0.4% -$3.42K 0.27% 88
2016
Q1 		$904K Buy
6,028
+218
+4% +$32.4K 0.27% 88
2015
Q4 		$943K Sell
5,810
-50
-0.9% -$7.86K 0.27% 87
2015
Q3 		$810K Sell
5,860
-36
-0.6% -$5.67K 0.25% 86
2015
Q2 		$905K Buy
5,896
+112
+2% +$17.9K 0.26% 91
2015
Q1 		$924K Sell
5,784
-376
-6% -$59.2K 0.26% 85
2014
Q4 		$981K Buy
6,160
+376
+7% +$58.6K 0.28% 85
2014
Q3 		$812K Buy
5,784
+316
+6% +$41.3K 0.23% 108
2014
Q2 		$647K Hold
5,468
– – 0.21% 114
2014
Q1 		$674K Buy
5,468
+140
+3% +$17K 0.23% 103
2013
Q4 		$608K Buy
+5,328
New +$606K 0.21% 116

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Winslow Evans & Crocker's AMGN Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Amgen (AMGN) stake by 47% in Q4 2020, buying an estimated $966K and bringing the position to 13,138 shares worth $3.02M. The position accounts for 0.57% of the portfolio, ranked #36.

Winslow Evans & Crocker first reported a position in AMGN in Q4 2013 and has held it in 29 quarters since. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Winslow Evans & Crocker held 13,138 shares of Amgen worth $3.02M as of Q4 2020.
  • Winslow Evans & Crocker bought 4,190 Amgen shares in Q4 2020, an estimated $966K.
  • Amgen made up 0.57% of Winslow Evans & Crocker's portfolio in Q4 2020, its #36 holding.
  • Winslow Evans & Crocker first reported a position in Amgen in Q4 2013 and has held it in 29 quarters since.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.